Effect of Immunotherapy on Humoral and Cellular Markers in Allergic Patients

  • S. Rak
  • L. Håkanson
  • P. Venge
Conference paper


The main feature of allergic disease is an IgE-mediated inflammation, while an essential feature of both allergic and nonallergic asthma is bronchial hyperresponsiveness (BHR). The term “bronchial hyperresponsiveness” generally refers to an increase in airway sensitivity against a number of pharmacological, physical and chemical stimuli. The different stimuli induce BHR through different pathways which may represent a variety of pathophysiological conditions. At least in allergic asthma the degree of nonspecific responsiveness to commonly used stimuli like histamine or methacholine seems to represent variable degrees of inflammation. Although many different cells play a role in this inflammatory process, the eosinophil granulocyte dominates the picture. A selective increase in the number of activated eosinophils has been found in circulating cells of peripheral blood, and also in BAL (bronchoalveolar lavage) fluid and biopsies from mucosa of allergic and nonallergic asthmatics. Another cell type of central importance for the inflammatory process in allergic asthmatic disease is the lymphocyte. T lymphocytes produce a number of cytokines with different properties, covering a large span of activities such as the effect on hematopoietic cells, leading to differentiation and maturation of cells central to the allergic process, mast cells and eosinophils. Another important activity is the helper function in production of IgE antibodies from B cells. The Th2 cell type orchestrates these processes by production of a selective array of cytokines: interleukin-3 (IL-3), IL-4, IL-5 and granulocyte/ macrophage-colony-stimulating factor (GM-CSF). This new understanding of the inflammatory process was possible due to the development of immunohistochemical and molecular techniques which have been applied to the biological material taken from patients affected with allergic disease.


Allergy Clin Immunol Pollen Season Allergen Challenge Allergic Inflammation Eosinophil Cationic Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Otsuka H, Mezawa A, Ohnishi M, Okubo K, Seki H, Okuda M (1991) Changes in nasal metachromatic cells during allergen immunotherapy. Clin Exp Allergy 21: 115–119PubMedCrossRefGoogle Scholar
  2. 2.
    Frigas E, Gleich GJ (1986) The eosinophil and pathophysiology of asthma. J Allergy Clin Immunol 77: 527–537PubMedCrossRefGoogle Scholar
  3. 3.
    Pipkorn U, Karlsson G, Enerbäck L (1988) The cellular response of the human allergic mucosa to natural allergen exposure. J Allergy Clin Immunol 82: 1046–1054PubMedCrossRefGoogle Scholar
  4. 4.
    Monchy de JGR, Kaufman HF, Venge P, Koeter G, Hansen HM, Sluiter HJ, Vries K (1985) Bronchoalveolar eosinophilia during allergen induced late asthmatic reaction. Am Rev Respir Dis 131: 373–386PubMedGoogle Scholar
  5. 5.
    Rak S, Hâkanson L, Sörenson S, Björnson A, Venge P (1991) The effect of immunotherapy on accumulation of eosinophils and production of eosinophil chemotactic activity in bronchoalveolar lavage of allergic asthmatics during the pollen season. J Allergy Clin Immunol 88: 878–888PubMedCrossRefGoogle Scholar
  6. 6.
    Rak S, Peterson C, Enander I (1991) The eosinophil granulae proteins (ECP, EPX) in acute asthma. Allergy and clinical immunological news. Abstracts of the XIVth international congress of allergology and clinical immunology, Kyoto, abstract 863Google Scholar
  7. 7.
    Fowler JW, Lowell FC (1966) The accumulation of eosinophils as an allergic response to allergen applied to the denuded skin surface. J Allergy 37: 19–28PubMedCrossRefGoogle Scholar
  8. 8.
    Furin MJ, Norman PS, Creticos P, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio R (1991) Immunotherapy decreases antigen-induced migration into the nasal cavity. J Allergy Clin Immunol 88: 27–32PubMedCrossRefGoogle Scholar
  9. 9.
    Norman PS (1981) Immunotherapy. Prog Allergy 32: 318–55Google Scholar
  10. 10.
    Durham SR, Varney V, Gaga M, Frew AJ, Jacobson M, Kay AB (1991) Immunotherapy and allergic inflammation. Clin Exp Allergy 21: 206–210PubMedCrossRefGoogle Scholar
  11. 11.
    Mossman TF, Cherwinski H, Bond HW (1986) Two types of murine helper T-cell clone. Definition according to profile of lymphokine activities and secreted proteins. J Immunol 136: 2348Google Scholar
  12. 12.
    Rocklin RE (1983) Clinical and immunological aspects of allergen-specific immunotherapy in patients with seasonal allergic rhinitis and/or allergic asthma. J Allergy Clin Immunol 72: 323–334PubMedCrossRefGoogle Scholar
  13. 13.
    Rak S, Hallden G, Sörensson S, Margari V, Scheynius A (1993) The effect of immunotherapy on T-lymphocyte subsets in peripheral blood and bronchoalveolar lavage fluid in pollen allergic patients. Allergy 48: 460–465PubMedCrossRefGoogle Scholar
  14. 14.
    Durham SR, Gaga M, Frew AJ, Varney V, Jacobson MR, Kay AB (1991) Immunotherapy suppresses T lymphocyte infiltration in the cutaneous late-phase reaction. J Allergy Clin Immunol 87: 412CrossRefGoogle Scholar
  15. 15.
    Creticos PS, Adkinson NF, Kagey-Sobotka A, Proud D, Meier HL, Naclerio RM, Lichtenstein LM, Norman PS (1985) Nasal challenge with ragweed pollen in hay fever patients: effect of immunotherapy. J Clin Invest 76: 2247–2253PubMedCrossRefGoogle Scholar
  16. 16.
    Rak S, Löwhagen O, Venge P (1988) The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen allergic patients. J Allergy Clin Immunol 82: 470–480PubMedCrossRefGoogle Scholar
  17. 17.
    Hâkanson L, Rak S, Dahl R, Venge P (1989) The formation of eosinophil and neutrophil chemotactic activity during a pollen season and after allergen challenge. J Allegy Clin Immunol 83: 933–939CrossRefGoogle Scholar
  18. 18.
    Rak S, Hâkanson L, Venge P (1990) Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen season. J Allergy Clin Immunol 86: 706–713PubMedCrossRefGoogle Scholar
  19. 19.
    Kuna P, Alam R, Kuzminska B, Rozniecki J (1989) The effect of preseasonal immunotherapy on the production of histamine releasing factor (HRF) by mononuclear cells from patients with seasonal asthma: results of a double blind, placebo-controlled, randomized study. J Allergy Clin Immunol 83: 816–824PubMedCrossRefGoogle Scholar
  20. 20.
    Tsicopoulos A, Tonnel AB, Vorng H, Joseph M, Wallaert B, Kusnierz JP, Pestel J, Capron A (1990) Lymphocyte mediated inhibition of platelet cytotoxic functions during Hymenoptera venom desensitization: characterization of suppresive lymphokine. Eur J Immunol 20: 1201–1207PubMedCrossRefGoogle Scholar
  21. 21.
    Calderon E, Lockey RF (1992) A possible role for adhesion molecules in asthma. J Allergy Clin Immun 90: 852–865PubMedCrossRefGoogle Scholar
  22. 22.
    Wagner CD, Gundel RD, Reilly P, Haynes N, Letts LG, Rothlein R (1990) Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 247: 456–459CrossRefGoogle Scholar
  23. 23.
    Vignola AM, Campbell AM, Chanez P, Bousquet J, Paul-Lacoste P, Michel FB, Godard P (1993) HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. Am Rev Respir Dis 148: 689–694PubMedCrossRefGoogle Scholar
  24. 24.
    Ciprandi G, Buscaglia S, Pesce G, Villaggio B, Bagnasco M, Canonica GW (1993) Allergic subjects express intercellular adhesion molecule-1 (ICAM-1) or CD54 on epithelial cells of conjunctiva after allergen challenge. J Allergy Clin Immunol 91: 783–792PubMedCrossRefGoogle Scholar
  25. 25.
    Canonica GW, Ciprandi G, Buscaglia S, Pesce G, Bagnasco M (1994) Adhesion molecules of allergic inflammation: recent insights into their functional roles. Allergy 49: 135–141PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • S. Rak
  • L. Håkanson
  • P. Venge

There are no affiliations available

Personalised recommendations